Varus Deformity
10
0
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
50.0%
-36.6% vs benchmark
10%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (10)
Persona Ti-Nidium Post-Market Clinical Follow-up
Persona SoluTion PPS Femur PMCF
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Cemented vs Cementless Persona Keel RCT
TO Plate Fixation vs. External Fixator Comparison (HTO Plate vs. ExFix Study)
Vanguard Rocc Post Market Surveillance
A Randomized Controlled Trial for Partial Knee Arthroplasty
Prospective Multi-Center Study on Vanguard With E1 Bearing
Assessment of Foot Alignment and Pressure After Correction of Varus Knee by High Tibial Osteotomy or Total Knee Replacement
The 3DKnee™ System: A Post-Market Study